Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection

EA Zhukovsky, RJ Morse, MV Maus - Current opinion in immunology, 2016 - Elsevier
cytotoxic T cells to tumor cells via BsAb and tumor targeting … , and the ultimate destruction
of the target cell by the ensuing … a universal requirement for redirected T cell cytotoxic activity […

[HTML][HTML] Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies

B Blanco, Á Ramírez-Fernández… - Frontiers in …, 2020 - frontiersin.org
… mechanisms from immune recognition and destruction, such as … Those bispecific ta-scFv
antibodies recognizing a tumor cell … be implemented to the generation of universal STAb-T cells. …

Bispecific antibodies enable synthetic agonistic receptor-transduced T cells for tumor immunotherapy

CH Karches, MR Benmebarek, ML Schmidbauer… - Clinical Cancer …, 2019 - AACR
… in the vicinity of the antibody-targeted tumor cell. We generated … be transduced into murine
cytotoxic T cells with comparable … -target effects or organ damage was being caused by SAR T

Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics

H Li, P Er Saw, E Song - Cellular & molecular immunology, 2020 - nature.com
… attack and lysis of target tumor cells. Although various bsAb … bsAb, namely, a universal effector
module and a target module, … , alleviating the collateral damage of adjacent healthy tissues…

[HTML][HTML] Bispecific T-cell engagers: towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their …

D Ellerman - Methods, 2019 - Elsevier
… that CD28-deficient cytotoxic T-cells were still capable of … D) The copy number of the
targeted antigen on the tumor cell … However, this is not an universal feature as some Ab formats …

Bispecific antibodies: design, therapy, perspectives

SE Sedykh, VV Prinz, VN Buneva… - Drug design …, 2018 - Taylor & Francis
… of cytotoxic T lymphocytes and tumor cells due to BsAb binding activates cytotoxic T cells and
promotes the destruction of tumor cells… A relatively universal method of BsAb preparation is …

Tumor burden limits bispecific antibody efficacy through T-cell exhaustion averted by concurrent cytotoxic therapy

EW Meermeier, SJ Welsh, ME Sharik, MT Du… - Blood cancer …, 2021 - AACR
damage, preferentially kills regulatory T cells (Treg), induces an acute secretory activating
phenotype in tumor cells … Tnfrsf17 is universally expressed in all normal and malignant PCs at …

[HTML][HTML] For whom the T cells troll? Bispecific T-cell engagers in glioblastoma

K Singh, KM Hotchkiss, AA Mohan… - … of Cancer, 2021 - ncbi.nlm.nih.gov
Bispecific antibodies tether tumor cells to T lymphocytes (… also lack a universally expressed
tumor-specific antigen which … and tumor cells (such as granzyme B-mediated damage to the …

[HTML][HTML] From mono-to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and …

S Albert, C Arndt, S Koristka, N Berndt, R Bergmann… - Oncotarget, 2018 - ncbi.nlm.nih.gov
… ) T cell therapy combining T cells engrafted with a universal CAR (UniCAR) and an antibody
(Ab)-based component referred to as target … effector cells to avoid permanent destruction of …

Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection

…, K Roose, A Smet, B Schepens, P Kufer, T Raum… - Antiviral research, 2017 - Elsevier
… for CD3ɛ present on cytotoxic T cells and one selective for … the ToxiLight non-destructive
cytotoxicity bioassay kit (Lonza) … human T lymphocytes by tumor cells armed with bifunctional …